HeartSciences Inc. (HSCS) Company Profile - Business Overview, Management Team & Corporate Information - Stocknear

HeartSciences Inc.

NASDAQ: HSCS · Real-Time Price · USD
3.33
0.00 (0.00%)
At close: Sep 05, 2025, 3:59 PM
3.33
0.00%
After-hours: Sep 05, 2025, 07:39 PM EDT

Company Description

HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness.

It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis.

The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024.

HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.

HeartSciences Inc.
HeartSciences Inc. logo
Country United States
IPO Date Jun 16, 2022
Industry Medical - Devices
Sector Healthcare
Employees 15
CEO Andrew Christopher Simpson

Contact Details

Address:
550 Reserve Street
Southlake, Texas
United States
Website https://heartsciences.com

Stock Details

Ticker Symbol HSCS
Exchange NASDAQ
Fiscal Year May - April
Reporting Currency USD
CIK Code 0001468492
CUSIP Number 42254E104
ISIN Number US42254E3027
Employer ID 26-1344466
SIC Code 3842

Key Executives

Name Position
Andrew Simpson Chief Executive Officer, President & Chairman of the Board of Directors
Danielle Watson Chief Financial Officer & Treasurer
Mark T. Hilz Chief Operating Officer, Secretary & Director

Latest SEC Filings

Date Type Title
Aug 22, 2025 8-K Current Report
Aug 04, 2025 424B5 Filing
Aug 04, 2025 8-K Current Report
Jul 30, 2025 4 Filing
Jul 30, 2025 8-K Current Report
Jul 24, 2025 8-K Current Report
Jul 24, 2025 10-K Annual Report
Jul 21, 2025 8-K Current Report
Jul 14, 2025 4 Filing
Jul 14, 2025 8-K Current Report